423 related articles for article (PubMed ID: 23563667)
1. Sphingolipids in obesity, type 2 diabetes, and metabolic disease.
Russo SB; Ross JS; Cowart LA
Handb Exp Pharmacol; 2013; (216):373-401. PubMed ID: 23563667
[TBL] [Abstract][Full Text] [Related]
2. Sphingolipids: players in the pathology of metabolic disease.
Cowart LA
Trends Endocrinol Metab; 2009 Jan; 20(1):34-42. PubMed ID: 19008117
[TBL] [Abstract][Full Text] [Related]
3. Intracellular localization of diacylglycerols and sphingolipids influences insulin sensitivity and mitochondrial function in human skeletal muscle.
Perreault L; Newsom SA; Strauss A; Kerege A; Kahn DE; Harrison KA; Snell-Bergeon JK; Nemkov T; D'Alessandro A; Jackman MR; MacLean PS; Bergman BC
JCI Insight; 2018 Feb; 3(3):. PubMed ID: 29415895
[TBL] [Abstract][Full Text] [Related]
4. Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.
Holland WL; Summers SA
Endocr Rev; 2008 Jun; 29(4):381-402. PubMed ID: 18451260
[TBL] [Abstract][Full Text] [Related]
5. Sphingolipids and phospholipids in insulin resistance and related metabolic disorders.
Meikle PJ; Summers SA
Nat Rev Endocrinol; 2017 Feb; 13(2):79-91. PubMed ID: 27767036
[TBL] [Abstract][Full Text] [Related]
6. Targeting sphingolipid metabolism in the treatment of obesity/type 2 diabetes.
Bellini L; Campana M; Mahfouz R; Carlier A; Véret J; Magnan C; Hajduch E; Le Stunff H
Expert Opin Ther Targets; 2015; 19(8):1037-50. PubMed ID: 25814122
[TBL] [Abstract][Full Text] [Related]
7. Ectopic lipid storage and insulin resistance: a harmful relationship.
Borén J; Taskinen MR; Olofsson SO; Levin M
J Intern Med; 2013 Jul; 274(1):25-40. PubMed ID: 23551521
[TBL] [Abstract][Full Text] [Related]
8. Sphingolipids: agents provocateurs in the pathogenesis of insulin resistance.
Lipina C; Hundal HS
Diabetologia; 2011 Jul; 54(7):1596-607. PubMed ID: 21468641
[TBL] [Abstract][Full Text] [Related]
9. Sphingolipids in Adipose: Kin or Foe?
Valentine Y; Cowart LA
Adv Exp Med Biol; 2022; 1372():15-29. PubMed ID: 35503171
[TBL] [Abstract][Full Text] [Related]
10. Lipidomic profiling reveals early-stage metabolic dysfunction in overweight or obese humans.
Mousa A; Naderpoor N; Mellett N; Wilson K; Plebanski M; Meikle PJ; de Courten B
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Mar; 1864(3):335-343. PubMed ID: 30586632
[TBL] [Abstract][Full Text] [Related]
11. Adipose tissue and ceramide biosynthesis in the pathogenesis of obesity.
Samad F; Badeanlou L; Shah C; Yang G
Adv Exp Med Biol; 2011; 721():67-86. PubMed ID: 21910083
[TBL] [Abstract][Full Text] [Related]
12. Sphingolipids in adipose tissue: What's tipping the scale?
Lambert JM; Anderson AK; Cowart LA
Adv Biol Regul; 2018 Dec; 70():19-30. PubMed ID: 30473005
[TBL] [Abstract][Full Text] [Related]
13. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
14. Autophagy and Mitochondria in Obesity and Type 2 Diabetes.
Sarparanta J; García-Macia M; Singh R
Curr Diabetes Rev; 2017; 13(4):352-369. PubMed ID: 26900135
[TBL] [Abstract][Full Text] [Related]
15. Insulin action and resistance in obesity and type 2 diabetes.
Czech MP
Nat Med; 2017 Jul; 23(7):804-814. PubMed ID: 28697184
[TBL] [Abstract][Full Text] [Related]
16. Sphingolipids in obesity and related complications.
Boini KM; Xia M; Koka S; Gehr TW; Li PL
Front Biosci (Landmark Ed); 2017 Jan; 22(1):96-116. PubMed ID: 27814604
[TBL] [Abstract][Full Text] [Related]
17. Sphingolipids metabolism in the salivary glands of rats with obesity and streptozotocin induced diabetes.
Garbowska M; Łukaszuk B; Mikłosz A; Wróblewski I; Kurek K; Ostrowska L; Chabowski A; Żendzian-Piotrowska M; Zalewska A
J Cell Physiol; 2017 Oct; 232(10):2766-2775. PubMed ID: 28369933
[TBL] [Abstract][Full Text] [Related]
18. Sphingolipids in High Fat Diet and Obesity-Related Diseases.
Choi S; Snider AJ
Mediators Inflamm; 2015; 2015():520618. PubMed ID: 26648664
[TBL] [Abstract][Full Text] [Related]
19. Antioxidants Supplementation Reduces Ceramide Synthesis Improving the Cardiac Insulin Transduction Pathway in a Rodent Model of Obesity.
Hodun K; Sztolsztener K; Chabowski A
Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684414
[TBL] [Abstract][Full Text] [Related]
20. Endoplasmic reticulum stress and development of insulin resistance in adipose, skeletal, liver, and foetoplacental tissue in diabesity.
Villalobos-Labra R; Subiabre M; Toledo F; Pardo F; Sobrevia L
Mol Aspects Med; 2019 Apr; 66():49-61. PubMed ID: 30472165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
